Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L Mason

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
The Lancet. Neurology|December 20, 2018
The hunt for better treatments for Huntington's diseaseRoger Barker, Sarah L Mason
Expert Opinion on Pharmacotherapy|November 5, 2015
Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literatureSarah L Mason, Roger A Barker
Expert Opinion on Emerging Drugs|May 21, 2009
Emerging drug therapies in Huntington's diseaseSarah L Mason, Roger A Barker
Nature Reviews. Neurology|March 16, 2011
Neurodegenerative disease: Tracking disease progress in Huntington diseaseRoger A Barker, Sarah L Mason
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Novel targets for Huntington's disease: future prospectsSarah L Mason, Roger A Barker
Nature Reviews. Neurology|December 11, 2013
Neurodegenerative disease: Mapping the natural history of Huntington diseaseRoger A Barker, Sarah L Mason
The Journal of Small Animal Practice|August 1, 2013
Genetics of ligneous membranitis in a family of Scottish terriersSarah L Mason, Peter McElroy, Tim Nuttall
The Veterinary Record|August 15, 2012
Ligneous membranitis in Scottish terriersSarah L Mason, Peter McElroy, Tim Nuttall
Journal of Huntington'S Disease|July 18, 2020
The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease PatientsMegha Anil, Sarah L Mason, Roger A Barker
Brain Sciences|July 2, 2021
Problems with Social Cognition and Decision-Making in Huntington's Disease: Why Is it Important?Sarah L Mason, Miriam Schaepers, Roger A Barker
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
The Lancet. Neurology|December 20, 2018
The hunt for better treatments for Huntington's diseaseRoger Barker, Sarah L Mason
Expert Opinion on Pharmacotherapy|November 5, 2015
Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literatureSarah L Mason, Roger A Barker
Expert Opinion on Emerging Drugs|May 21, 2009
Emerging drug therapies in Huntington's diseaseSarah L Mason, Roger A Barker
Nature Reviews. Neurology|March 16, 2011
Neurodegenerative disease: Tracking disease progress in Huntington diseaseRoger A Barker, Sarah L Mason
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Novel targets for Huntington's disease: future prospectsSarah L Mason, Roger A Barker
Nature Reviews. Neurology|December 11, 2013
Neurodegenerative disease: Mapping the natural history of Huntington diseaseRoger A Barker, Sarah L Mason
The Journal of Small Animal Practice|August 1, 2013
Genetics of ligneous membranitis in a family of Scottish terriersSarah L Mason, Peter McElroy, Tim Nuttall
The Veterinary Record|August 15, 2012
Ligneous membranitis in Scottish terriersSarah L Mason, Peter McElroy, Tim Nuttall
Journal of Huntington'S Disease|July 18, 2020
The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease PatientsMegha Anil, Sarah L Mason, Roger A Barker
Brain Sciences|July 2, 2021
Problems with Social Cognition and Decision-Making in Huntington's Disease: Why Is it Important?Sarah L Mason, Miriam Schaepers, Roger A Barker
Pageof 6